Carzano, Italy

Stefania Agostini

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 2012.



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stefania Agostini: Innovator in Radiodiagnostic Imaging

Introduction

Stefania Agostini is a prominent inventor based in Carzano, Italy. She has made significant contributions to the field of radiodiagnostic imaging through her innovative work. Her research focuses on the development of compounds that enhance imaging techniques, which are crucial for medical diagnostics.

Latest Patents

Stefania holds a patent for an "Intermediate compound of technetium nitride complex for radiodiagnostic imaging." This bisphosphonoamine compound is represented by a specific formula, where R1, R2, R3, R4, and R5 are independently an alkyl group having 1 to 6 carbon atoms, and n is an integer of 1 to 6. This compound serves as an essential intermediate for preparing a technetium nitride complex, which is extremely useful in radiodiagnostic imaging.

Career Highlights

Stefania Agostini is associated with Nihon Medi-Physics Company, Limited, where she applies her expertise in developing advanced imaging technologies. Her work has been instrumental in improving the accuracy and effectiveness of diagnostic imaging methods.

Collaborations

Stefania has collaborated with notable colleagues, including Fiorenzo Refosco and Shinji Tokunaga. These partnerships have fostered innovation and have contributed to the advancement of radiodiagnostic imaging technologies.

Conclusion

Stefania Agostini's contributions to the field of radiodiagnostic imaging highlight her role as a leading inventor. Her innovative work continues to impact medical diagnostics positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…